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Abstract: Three cases of candida endophthalmitis complicating critical illness in young 
adult surgical patients with implications for safer practice are presented. We highlight how 
early ophthalmological examination can aid in the management of such critically ill patients. 
Clinicians need to be vigilant for the early diagnosis and aggressive treatment of hospital 
acquired opportunistic candida infection in at risk patients. Time may be of the essence as 
sight and life are at risk.
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Introduction
Endogenous Candida endophthalmitis is a serious sight threatening condition. We 
present three cases seen over a 2 year period; all were young adult surgical patients 
treated in intensive care units. We highlight how early ophthalmological examination 
can aid in the management of such critically ill patients.
Patient 1
A 33-year-old female was referred to the eye clinic complaining of ﬂ  oaters and visual 
loss. Emergency cesarean section for fetal distress had been required 3 weeks previ-
ously, complicated by the HELLP syndrome (Hemolysis, Elevated Liver enzyme, 
and Low Platelets), hypertension and renal failure. She had required admission to the 
intensive care unit. Candida albicans septicemia had developed, conﬁ  rmed by blood 
cultures. Candida was also isolated from patient’s central line. Fluconazole 400 mg 
daily by intravenous injection for one week, followed by 200 mg daily orally had been 
administered. The patient’s visual symptoms were only reported to nursing staff when 
her general condition had improved. The visual acuity was 6/24 Snellen right eye and 
6/9 left eye. Ocular examination revealed bilateral vitritis and multiple creamy-white, 
well circumscribed retinal lesions (Figure 1). White, forward extending vitreous 
opacities – reminiscent of a ‘string of pearls’ in their appearance – were observed in 
the left eye (Figure 2). The working clinical diagnosis was that endogenous Candida 
endophthalmitis was present. An intravitreal injection of 10 μg of amphotericin B 
was administered to the left eye. Oral ﬂ  uconazole 100 mg daily was administered 
for 5 weeks. The retinal lesions disappeared within 3 months. Vision in the left eye 
recovered fully while the right eye required further surgery due to macular hole 
formation. Patient’s ﬁ  nal Snellen visual acuity was 6/12 right, 6/6 left.
Patient 2
A 24-year-old female underwent open cholecystectomy which was complicated by the 
post-operative development of a subphrenic abscess. An acute confusional state and 
respiratory distress requiring endotracheal intubation and ventilation in the intensive care 
unit developed. Broad spectrum intravenous antibiotics were administered for suspected Clinical Ophthalmology 2007:1(4) 552
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septicemia. Lung abscesses were detected on chest X-ray 
and computerized tomography (CT) scan. Systemic fungal 
infection was suspected and an ophthalmological opinion for 
fundoscopy was requested. Recording of visual acuity was 
not possible as the patient was critically ill. Multiple creamy-
white intra-retinal lesions with Roth spots were observed in 
both eyes. The clinical picture was considered suggestive of 
Candida chorioretinitis. This prompted reconsideration of 
her clinical condition and intravenous ﬂ  uconazole 400 mg 
daily was initiated. C. albicans was isolated from specimens 
from a drain in the abdomen and from blood and sputum 
specimens. The patient’s condition improved gradually with 
full recovery in 6 weeks. The visual outcome was 6/6 Snellen 
acuity in both eyes.
Patient 3
A 34-year-old female was admitted with a 4 week history of 
vomiting, diarrhea, abdominal pain, and pyrexia. Flexible 
sigmoidoscopy showed ulceration suggestive of inﬂ  amma-
tory bowel disease. Intravenous hydrocortisone followed by 
oral steroids was administered to good effect and she was 
discharged home after one week. However she re-presented 
with further diarrhea eight days later. After failing to respond 
to further systemic steroid treatment, oral administration of 
azathioprine 100 mg and inﬂ  iximab 300 mg by intravenous 
infusion was prescribed. After some initial improvement, her 
condition deteriorated further and a subtotal colectomy, with 
formation of an ileostomy and a recto-sigmoid mucous ﬁ  stula 
was undertaken. The bowel specimen had histo-pathological 
evidence of severe ulcerative colitis with cytomegalovirus 
infection. Her post-operative course was complicated by 
intra-abdominal sepsis with small bowel obstruction requir-
ing further laparotomy. Nineteen days following the subtotal 
colectomy, her condition worsened with intermittent pyrexia, 
tachycardia, and tachypnea. A total of 160 mg of gentamicin, 
2 g of cefotaxime, and 1.5 g metronidazole were administered 
intravenously daily. When Candida species was isolated 
from a previously sited central line sent for microbiological 
examination ﬂ  uconazole 100 mg daily orally was prescribed. 
An ophthalmological opinion for fundoscopy was requested. 
The distance visual acuity recording on a Snellen chart was 
not possible. Bedside testing of near vision was normal. 
Three small white yellow vitreous opacities were observed 
in the right eye. Several Roth spots were observed in the left 
fundus. The ophthalmological ﬁ  ndings were considered con-
sistent with Candida endophthalmitis complicating systemic 
Figure 1 Colour photograph image of right fundus showing creamy white lesions involving the fovea and mild disc swelling.Clinical Ophthalmology 2007:1(4) 553
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Candida septicemia. Intravenous ﬂ  uconazole 400 mg daily was 
therefore administered. C. albicans was subsequently isolated 
from blood culture. Intravitreal amphotericin B injection was 
not possible due to the patient’s ill-health and the inability to 
be transferred to operating theatre. Acute respiratory distress 
syndrome with severe acidosis followed. Three days later, 
fatal cardio-respiratory collapse occurred. Multi-organ failure, 
disseminated candidiasis (with involvement of the kidneys, 
heart, and thyroid), and inﬂ  ammatory bowel disease were 
reported at autopsy. Post mortem ocular tissue examination 
was not undertaken.
Discussion
Endogenous, or metastatic, endophthalmitis is rare. Fungal 
organisms account for the majority of such cases, of which 
C.albicans is the pathogen most often responsible (Sallam 
et al 2006). Systemic Candida infection in critically ill 
patients in hospital high dependency and intensive care 
units is problematic and increasing (Schelenz and Gransden 
2003).
Risk factors for the occurrence of disseminated Candida 
infection in critically ill adults include; the use of broad-spectrum 
intravenous antibiotics, the placement of central venous 
devices, parenteral nutrition following major surgery (eg, 
abdominal surgery with intestinal wall disruption), and 
immunosuppression (Munoz et al 2000; Tanaka et al 2001; 
Schelenz and Gransden 2003). Intravenous heroin abuse-
utilizing proprietary lemon juice as a solvent – is a further 
risk factor in nonsurgical adults (Bibes et al 1992).
Symptoms of endogenous endophthalmitis complicating 
disseminated Candida infection include the recent onset 
of ﬂ  oaters and reduced vision (Sallam et al 2006). Impor-
tantly, affected patients in critical care settings may be too 
unwell to communicate such visual symptoms to staff. 
Vitreous opacities with single, or multiple, creamy-white, 
well circumscribed chorio-retinal lesions may be observed 
by ophthalmoscopy. These lesions contain the organisms 
with surrounding granulomatous and suppurative host 
reaction (Sallam et al 2006). The clinical diagnosis of 
Candida endophthalmitis is reserved for eyes that have 
ophthalmoscopic signs of vitreous involvement. The vitreous 
opacities often form in chain like patterns, extending forward 
into the vitreous cavity giving an appearance reminiscent of 
a ‘string of pearls’ or ‘balls of ﬂ  uff ’.
Ocular involvement in systemic candidiasis varies in 
published studies, because of various case ascertainment 
Figure 2 Color photograph image of the left fundus showing ‘string of pearls’, appearance of vitreous opacities inferiorly, and mild disc swelling.Clinical Ophthalmology 2007:1(4) 554
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methodologies, with ranges from 2% to over 45% of patients 
being affected (Edwards et al 1974; Donahue et al 1994; 
Feman et al 2002; Peyman et al 2004). By the time Candida 
endophthalmitis becomes symptomatic, two thirds of 
patients may have developed disease in both eyes, and more 
than half have multiple lesions and vitreous involvement 
(Edwards et al 1974).
The early stages of ocular Candida infection may respond to 
high doses of systemic antifungal agents (Smiddy 1998; Sallam 
et al 2006). As ﬂ  uconazole has excellent ocular penetration it 
is considered the treatment agent of ﬁ  rst choice. Resistance to 
ﬂ  uconazole is estimated to be as low as 5% at present (Charlier 
et al 2006). Intra-vitreal injection of amphotercin B may be 
required for more advanced cases of Candida endophthal-
mitis ocular involvement (ie, with vitreous involvement) and 
those who responded slowly to systemic treatment alone (like 
Patient 1 in this report). Variconazole and caspofungin are 
recently available new drugs that can be given systemically and 
intravitreally with promising results (Breit et al 2005). Vitrec-
tomy to reduce the ocular inﬂ  ammatory and fungal load and 
improve vision may also be required. The outcome for vision 
when ocular involvement occurs is favorable when treatment 
is administered early, before the onset of retinal complications 
such as epiretinal membrane formation or development of 
macular hole (Smiddy 1998). Importantly it is vital to recognize 
that patients with Candida endophthalmitis in hospital care are 
often critically ill and at risk of multi-organ fungal infection and 
death (Menezes et al 1994; Schiedler et al 2004; Leibovitch et 
al 2005). Mortality rates of 50% or more have been reported 
(Menezes et al 1994). Clinicians should have a high degree of 
suspicion of Candida super-infection and a low threshold for 
aggressive treatment in such at risk patients.
Ocular examination in patients with Candida septicemia 
has been recommended (Donahue et al 1994; Nightingale et al 
1995; Piek et al 1998; Feman et al 2002; Rodriguez-Adrian 
et al 2003). We suggest that ophthalmological consultation 
should be requested when systemic or disseminated Candida 
infection is suspected, as the ophthalmoscopy features of 
Candida endophthalmitis are characteristic. This clinical 
diagnosis should lead to early high dose systemic anti-fungal 
treatment without delay. Microbiological conﬁ  rmation may 
take some time, may only become positive late in the disease 
and has a reported sensitivity as low as 50% (Ellepola et al 
2005). Detection of Candida DNA using PCR assay offers a 
more rapid and sensitive test, but it is not widely available yet 
(Sallam et al 2006). As ﬂ  uconazole resistance is infrequent in 
systemic C. albicans infections initial aggressive treatment 
with this agent should be started promptly and this agent 
achieves good results in ocular involvement (Akler et al 
1995). Early advice from a clinical microbiologist is critical. 
Identiﬁ  cation of Candida species with anti-fungal sensitivities 
should be undertaken and will guide continuing treatment.
Acknowledgement
We are grateful to Prof David Denning and Dr Leela Joseph 
for comments on an early draft of this paper. There are no 
competing interests. This paper was unfunded.
References
Akler ME, Vellend H, McNeely DM, et al. 1995. Use of ﬂ  uconazole in 
the treatment of candidal endophthalmits. Clin Infect Dis, 20:657–64.
Bisbe J, Miro JM, Latorre X, et al. 1992. Disseminated candidiasis in addicts 
who use brown heroin: report of 83 cases and review. Clin Infect Dis, 
15:910–23.
Breit SM, Hariprasad SM, Mieler WF, et al. 2005. Management of endog-
enous fungal endophthalmitis with voriconazole and caspofungin. Am 
J Ophthalmol, 139(1):135–40.
Charlier C, Hart E, Lefort A, et al. 2006. Fluconazole for the manage-
ment of candidiasis: Where do we stand after 15 years? J Antimicrob 
Chemother, 57(3):384–410.
Donahue SP, Greven CM, Zuravleff JJ, et al. 1994. Intraocular candidiasis 
in patients with Candidemia. Clinical implications derived from a 
prospective multicenter study. Ophthalmology, 101(7):1302–9.
Edwards JE, Foos RY, Montgomerie JZ, et al. 1974. Ocular manifestations 
of Candida septicemia: Review of seventy-six cases of haematogenous 
Candida endophthalmitis. Medicine, 53:47–75.
Ellepola AN, Morrison CJ. 2005. Laboratory diagnosis of invasive candi-
diasis. J Microbiol, 43:65–84.
Feman SS, Nichols JC, Chung SM, et al. 2002. Endophthalmitis in 
patients with disseminated fungal disease. Trans Am Ophthalmol Soc, 
100:67–70.
Leibovitch I, Lai T, Raymond G, et al. 2005. Endogenous endophthalmitis: 
a 13-year review at a tertiary hospital in South Australia. Scand J Infect 
Dis, 37(3):184–9.
Menezes AV, Sigesmund DA, Demanjo WA, et al. 1994. Mortality of 
hospitalizes patients with Candida endophthalmitis. Arch Intern Med, 
154(18):2093–7.
Munoz P, Burillo A, Bouza E. 2000. Criteria used when initiating antifungal 
therapy against Candida spp. In the intensive care unit. Int J Antimicrob 
Agents, 15(2):83–90.
Nightingale JM, Simpson AJ, Towler HM, et al. 1995. Fungal feeding-line 
infections: beware the eyes and teeth. J R Soc Med, 88(5):258–63.
Piek JJ, Knot EA, Schooneveld MJ, et al. 1998. Candidemia, look at the 
eyes. Intens Care Med, 14(2):173–5.
Rodriguez-Adrian LJ, King RT, Tamayo-Derat LG, et al. 2003. Retinal 
lesions as clues to disseminated bacterial and Candida infections: 
frequency, natural history, and aetiology. Medicine, 82(3):187–202.
Sallam A, Lynn W, McCluskey P, et al. 2006. Endogenous Candida endo-
phthalmitis. Expert Rev Anti Infect Ther, 4(4):675–85.
Schelenz S, Gransden WR. 2003. Candidemia in a London teach-
ing hospital: analysis of 128 cases over a 7-year period. Mycoses, 
46(9–10):390–6.
Schiedler V, Scott IU, Flynn HW, et al. 2004. Culture-proven endogenous 
endophthalmitis: clinical features and visual acuity outcomes. Am J 
Ophthalmol, 137(4):725–31.
Smiddy WE. 1998. Treatment outcomes of endogenous fungal endophthal-
mitis. Curr Opin Ophthalmol, 9(3):66–70.
Tanaka M, Kobayashi Y, Takebayashi H, et al. 2001. Analysis of predispos-
ing clinical and laboratory ﬁ  ndings for the development of endogenous 
fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 
patients. Retina, 21(3):203–9.